Head to Head Comparison: Onto Innovation (NYSE:ONTO) and Manhattan Scientifics (OTCMKTS:MHTX)

Onto Innovation (NYSE:ONTO) and Manhattan Scientifics (OTCMKTS:MHTX) are both computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, dividends, risk, valuation, earnings and institutional ownership.

Institutional & Insider Ownership

98.3% of Onto Innovation shares are held by institutional investors. 0.6% of Onto Innovation shares are held by company insiders. Comparatively, 11.8% of Manhattan Scientifics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Onto Innovation and Manhattan Scientifics”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Onto Innovation	$1.04 billion	5.13	$201.67 million	$4.04	26.87
Manhattan Scientifics	$50,000.00	0.00	-$1.16 million	N/A	N/A

Onto Innovation has higher revenue and earnings than Manhattan Scientifics.

Risk and Volatility

Onto Innovation has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Comparatively, Manhattan Scientifics has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Onto Innovation and Manhattan Scientifics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Onto Innovation	0	2	5	0	2.71
Manhattan Scientifics	0	0	0	0	0.00

Onto Innovation presently has a consensus target price of $137.8571, suggesting a potential upside of 27.00%. Given Onto Innovation’s stronger consensus rating and higher probable upside, analysts clearly believe Onto Innovation is more favorable than Manhattan Scientifics.

Profitability

This table compares Onto Innovation and Manhattan Scientifics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Onto Innovation	19.29%	14.38%	13.14%
Manhattan Scientifics	N/A	N/A	N/A

Summary

Onto Innovation beats Manhattan Scientifics on 10 of the 11 factors compared between the two stocks.

About Onto Innovation

Onto Innovation Inc. engages in the design, development, manufacture, and support of process control tools that performs optical metrology. The company offers lithography systems and process control analytical software. It also offers process and yield management solutions, and device packaging and test facilities through standalone systems for optical metrology, macro-defect inspection, packaging lithography, and transparent and opaque thin film measurements. In addition, the company provides process control software portfolio that includes solutions for standalone tools, groups of tools, and enterprise-or factory-wide suites. Further, it engages in systems software, spare parts, and other services, as well as offers software licensing services. The company's products are used in semiconductor and advanced packaging device manufacturers; silicon wafer; light emitting diode; vertical-cavity surface-emitting laser; micro-electromechanical system; CMOS image sensor; power device; analog device; RF filter; data storage; and various industrial and scientific applications. Onto Innovation Inc. was founded in 1940 and is headquartered in Wilmington, Massachusetts.

About Manhattan Scientifics

Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.